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Hypotheses
HIV-1 Tat expression will accelerate aging as assessed by
cognitive, affective, and antinociceptive comorbidities. Tat
will interact with neuroendocrine aging such that




HIV-1 Tat Contributes to Disrupt Endocrine System
HIV-1 Tat Expression, in Aged Mice, Increases Mechanical Allodynia. 
Neither Tat nor Aging Impair Thermal Hyperalgesia
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Figure 1: (A) Tat expression increased reference memory errors in males and post-estropausal females.  (B) Post-estropausal females had a greater 
latency to escape compared to pre-estropausal females. * indicates Tat+ significantly differs from respective Tat- control group. † indicates 
significant difference from pre-estropausal group (repeated measures ANOVA, p < 0.05).
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HIV-1 Tat Expression or Post-Estropausal Status Exacerbates 




Background Tat Exposure in Aged Males and Post-Estropausal Females Increases Memory Errors and Latency to Escape
v Combination antiretroviral therapy (cART) has significantly
reduced the incidence of HIV-1 associated dementia and
increased life expectancy among infected patients. However,
~50% of the HIV+ population still suffer from neurological and
psychological symptoms, including increased incidence of
cognitive deficits, anxiety/depression, and neuropathic pain,
collectively called neuroHIV [1,3].
v HIV-1 proteins, such as the trans-activator of transcription
(Tat), are neurotoxic, remain present in the central nervous
system despite combined antiretroviral therapy, and are thought
to contribute to neuroHIV [2, 4].
v The U.S. HIV+ population is aging with ~60% over the age of
50 years old. These individuals experience accelerated aging
and characterized by vulnerability to numerous age-related
comorbidities, including endocrine and immune dysfunction,
neurocognitive deficits, vascular and metabolic disorders [4-6].
v HIV-1 Tat protein, cART, and chronological aging can disrupt
endocrine function, dysregulate the hypothalamic-pituitary-
gonadal axis, and impair steroidogenesis. [4-7].
Animal Housing
HIV-1 Tat transgenic mice were generated in the vivarium at the University of Mississippi (University, MS). HIV-1
Tat1-86 protein is expressed via a glial fibrillary acidic protein (GFAP)-driven, tetracycline (Tet)-on promoter
activated by doxycycline (30 mg/kg, i.p.). Aged (15-19 mos), male (n=26) and female (n=48) mice that expressed Tat
(Tat+) and their non-Tat-expressing counterparts (Tat-) were housed (4-5/cage) in a temperature- and humidity-
controlled room on a reversed 12:12 h light/dark cycle (lights off at 20:00 h).
Vaginal Cytology
Vaginal lavage was used to collect epithelial cells to determine estrous cycle phase. The morphology of cells and/or
the presence or absence of leukocytes were used to identify estrous stages; proestrus (characterized by a
predominance of nucleated cells), estrous (characterized predominantly by cornified cells), metestrus (characterized
by nucleated, cornified, leukocytic cells), and diestrous (characterized by a majority presence of leukocytes).
Open Filed (OF)
Mice were placed at the center area of an open field apparatus (40×40×35 cm) and allowed to freely explore for 5
min. Mice were digitally tracked and recorded by ANY-maze software tracking system. A greater proportion of
central entries was used as an index for anti-anxiety-like behavior. Total distance travelled was used as an index for
locomotor activity.
Elevated Plus Maze (EPM)
Mice were placed in the center of an elevated plus maxe (5× 5 cm) and allowed to explore the maze for 5 min.
Animals were tracked digitally using Noldus Ethovision tracking software. The latency to enter, and time spent on,
the open arms of the maze were considered an index of anti-anxiety-like behavior.
Radial Arm Water Maze (RAWM)
Mice were placed in an 8-arm radial arm water maze with the goal of reaching a hidden platform. During training,
mice performed 6 trials/day with each trial ending when the mouse either reached the hidden platform or after 60 s.
When mice failed to locate the platform, they were gently guided to it and allowed to remain for 15 s. 8 days after
acquisition, memory was assessed in consecutive reversal probe and reversal learning trials. The total number of
errors and greater latency to reach the platform were used as indictor of a hippocampus-dependent learning and
memory deficits.
Electronic Von Frey (eVF) Mechanical Allodynia
The eVF probe was applied to the middle plantar surface of the hind paw and force was incrementally increased until
paw withdrawal. The required force (g) to produce the withdrawal was recorded. Each mouse was tested in eight
trials (4: right and 4: left) alternating between right and left paws with a 3-min interval break between trials.
Thermal Hyperalgesia
A radiant heat source was applied to the middle plantar surface of the hind paw (2.5 ̊C/sec) until paw withdrawal.
Each mouse underwent 4 trials (2: right and 2: left) with a 3 -5 min interval break between trials.
Steroid Extraction/ Enzyme-Linked Immunosorbent Assay (ELISA)
Steroids were extracted from serum via ether-snap freezing. Samples were reconstituted in extraction buffer and
assessed via ELISA for corticosterone, estradiol, and testosterone per manufacturer instructions (Neogen Life
Sciences, Lexington, KY). Plates were read on a CLARIOstar microplate reader (BMG Labtech Inc., Cary,NC) at
650 nm absorbance.
Figure 2: (A) Irrespective of Tat exposure, post-estropausal status increased anxiety-like behavior in the open field. (B) Neither Tat nor aging
influenced distance traveled in the open field. (C) Tat+ males had a greater latency to enter the open arm of an elevated plus maze. (D) Pre-
estropausal females demonstrated decreased anxiety–like behavior in the elevated plus maze compared to all other groups. * indicates Tat+
significantly differs from respective Tat- control group. ‡ indicates significant difference from all other groups (2-way ANOVA, p < 0.05).
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Figure 3: (A) There was a main effect for Tat expression to increase mechanical allodynia. (B) Neither Tat nor endocrine status influenced thermal 
hyperalgesia. * indicates Tat+ significantly differs from respective Tat- control group (2-way ANOVA , p < 0.05).
Figure 4: (A) Post-estropausal females exposed to Tat had significantly increased circulating corticosterone. (B) Tat+ males and
post-estropausal females had significantly less circulating estradiol (E2). (C) Males had more circulating testosterone (T) than
females. (D) The E2:T ratio increased in Tat+, pre-estropausal females. * Tat+ significantly differs from Tat- control. †
significant difference from pre-estropausal group. ‡ significant difference from all other groups (2-way ANOVA, p < 0.05).
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Thus, HIV-1 Tat promoted cognitive deficits, anxiety–like behavior, and
allodynia among aged mice in a manner coincident with their neuroendocrine
aging status. Aged females that maintained their reproductive capacity may be
more resilient to Tat’s accelerating effects on age. Future studies will determine
whether administration of exogenous steroid hormones to aged Tat-exposed
exert cognitive, affective, and nociceptive benefits.
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v HIV-1 Tat expression and aging significantly impaired cognition. Among
males, those exposed to Tat made more errors. Post-estropausal females had
longer latencies to find the platform than did their pre-estropausal counterparts
and made more errors when Tat-exposed (Fig. 1A-B).
v HIV-1 Tat expression increased anxiety-like behavior among males (Fig. 2C)
and transition to post-estropause increased anxiety-like behavior in an open
field (Fig. 2A) and elevated plus maze (Fig. 2D).
v Tat increased mechanical allodynia with no effect on thermal hyperalgesia
(Fig. 3A-B).
v In post-estropause, Tat increased corticosterone and decreased estradiol.
Whereas, Tat-exposed males had increased estradiol. The E:T ratio was
increased in Tat-exposed pre-estropausal females (Fig. 4A-D).
Conclusion
‡
